Skip to search formSkip to main contentSkip to account menu

LY3022855

National Institutes of Health

Related topics

Related topics

1 relation
Anti-CSF1R Monoclonal Antibody IMC-CS4

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Phase 1 study of LY3022855, a colony-stimulating factor-1 receptor (CSF-1R) inhibitor, in patients with metastatic breast cancer (MBC) or metastatic castration-resistant prostate cancer (MCRPC).
2548 Background: Tumor-associated macrophages (TAM) correlate with increased invasiveness, growth, and immunosuppression… 
2017
2017
A phase I study of LY3022855, a colony-stimulating factor-1 receptor (CSF-1R) inhibitor, in patients (pts) with advanced solid tumors.
2523Background: Binding of CSF-1 to the CSF-1 receptor (CSF-1R) results in proliferation, differentiation, and migration of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)